Canton Strategic Holdings (CNTN) Interest Expenses (2020 - 2025)
Canton Strategic Holdings (CNTN) posted Interest Expenses of $4065.0 for Q4 2025, down 57.87% on a QoQ basis from $9648.0 in Q3 2025, and up 436.28% year-over-year from $758.0 in Q4 2024.
Canton Strategic Holdings (CNTN) Interest Expenses (2020 - 2025) Analysis & Trends
Canton Strategic Holdings' Interest Expenses history runs 6 years deep, the most recent figure standing at $4065.0 for Q4 2025.
- Quarterly Interest Expenses rose 436.28% year-over-year to $4065.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $19874.0 (up 13.86% YoY) and the FY2025 annual result came in at $5.1 million, down 50.15% from the prior year.
- Interest Expenses was $4065.0 for Q4 2025 at Canton Strategic Holdings, down from $9648.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $1.6 million in Q1 2022 and bottomed at -$1.6 million in Q4 2022.
- A 5-year average of $50664.7 and a median of $6149.5 in 2023 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 979.69% in 2022, while the deepest fall reached 711.53% in 2022.
- Canton Strategic Holdings' Interest Expenses stood at $258000.0 in 2021, then slumped by 711.53% to -$1.6 million in 2022, then jumped by 100.02% to $354.0 in 2023, then jumped by 114.12% to $758.0 in 2024, then jumped by 436.28% to $4065.0 in 2025.
- Business Quant data shows CNTN's Interest Expenses at $4065.0 in Q4 2025, $9648.0 in Q3 2025, and $6161.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,065.00 |
| Dec 31, 2025 | 4,065.00 |
| Sep 30, 2025 | 9,648.00 |
| Sep 30, 2025 | 9,648.00 |
| Jun 30, 2025 | 6,161.00 |
| Jun 30, 2025 | 6,161.00 |
| Mar 31, 2025 | 8,471.00 |
| Mar 31, 2025 | 8,471.00 |
| Dec 31, 2024 | 758.00 |
| Dec 31, 2024 | 758.00 |
| Sep 30, 2024 | 3,009.00 |
| Sep 30, 2024 | 3,009.00 |
| Jun 30, 2024 | 5,217.00 |
| Jun 30, 2024 | 5,217.00 |
| Mar 31, 2024 | 4,700.00 |
| Mar 31, 2024 | 4,700.00 |
| Dec 31, 2023 | 354.00 |
| Dec 31, 2023 | 354.00 |
| Sep 30, 2023 | 3,496.00 |
| Sep 30, 2023 | 3,496.00 |